Biopharma Plastics Market Size, Share, Demand & Trends by 2033
Biopharma plastics are being utilized for providing
higher stability to several applications including depth filters, syringes, and
containers. Increased preference for use of high-grade polymers material in the
construction of single-use biopharma
plastics has fuelled the market growth.
Increasing health concern, and growth in healthcare
expenditure are expected to drive the market for biopharma plastics along with
polymers. Moreover, the presence of large-scale PP molding facilities and the
manufacturing sector is projected to propel the market growth over the forecast
period.
Industry leaders are investing heavily in R&D to
provide biopharmaceutical products that suit every aspect of consumer needs,
which is driving the biopharma plastics market. North America dominates the
biopharma plastics market due to the presence of key manufacturers of biopharma
plastics such as Celanese Corporation, Eastman Chemical Co., and DuPont. Europe
is the second-largest shareholder in the market, mainly due to the growing
political support and favorable reimbursement regulations for medical devices.
Get Sample PDF Of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15942
Key Takeaways from the Market Study
- As
of 2023, the biopharma plastics market was valued at US$ 5.42 Billion
- From
2023 to 2033, the biopharma plastics industry is poised to grow at an
11.4% CAGR
- By
2033, the biopharma plastics market is slated to reach a valuation of US$
15.95 Billion
- By
polymer type, the polyvinyl chloride segment accounted for the largest
share of 21.5% and is expected to continue this trend over the forecast
period.
- China
is poised to yield a CAGR of 11.3% with respect to biopharma plastics in
2033
“Growing healthcare spending and
increasing application of biopharma plastics are expected to radically
transform the biopharma plastics market in the coming years,” comments an
analyst at FMI.
Competitive Landscape
BASF SE, LyondellBasell Industries Holdings B.V.,
SABIC, LG chem, Toray Industries, Inc., Solvay, Dow, Inc., DuPont de Nemours,
Inc., Saint-Gobain Performance Plastics, Tekni-Plex are some of the key players
in the biopharma plastics industry.
The manufacturers are involved in the production of biopharma
plastics in a larger capacity. Research and innovation are also conducted to
launch innovative plastics for biopharmaceutical products. Also, some of the
key players are acquiring small pharmaceutical companies to increase their
production capacity.
- In
September 2022 – LyondellBasell announced today that Hanwha Solutions
Corporation will use the LyondellBasell Lupotech T high-pressure
polyethylene technology at a new site in Yeosu, South Korea.
The Lupotech T process technology will be used for a 300 kiloton
per year (KTA) vinyl acetate copolymer (EVA) line.
- In
July 2022 – DuPont celebrated the opening of its new DuPont™Liveo™ Healthcare
Solutions manufacturing facility located at the Cooper River Site in
South Carolina. The new facility will expand capacity for
biopharmaceutical tubing extrusion to meet increased demand from Liveo™ customers
- In
October 2021 – Tekni-Plex Healthcare has acquired precision extrusion
manufacturer Johnson Plastic Group (JPG) as part of a strategy to expand
the company’s patient care solutions platform. The acquisition expands
Tekni-Plex Healthcare’s medical device capabilities and broadens the
division’s global footprint by adding a presence in Mexico.
- In
November 2022 – Solvay, a leading supplier of advanced materials, has
teamed up with French start-up Ostiumin a joint project designed to
enable the mechanical recycling of end-of-life single-use surgical
instruments molded in glass-fiber reinforced Ixef® polyarylamide
(PARA) from Solvay’s portfolio of specialty polymers
Key Segments Covered in the Biopharma
Plastics Market Industry Survey
Biopharma Plastics Market by Polymer Type:
- Polyethylene
– PE
- Polypropylene
– PP
- Acrylonitrile
Butadiene Styrene – ABS
- Polyethylene
Terephthalate – PET
- Polyvinyl
Chloride – PVC
- Polytetrafluoroethylene
– PTFE
- Other
Biopharma Plastics Market by Application:
- Protective
Wear
- Container
- Bioreactor
Bags
- Syringes
- Depth
Filter
- Disposable
Medical Connectors
- Others
Biopharma Plastics Market by Region:
- North
America
- Latin
America
- Europe
- Asia
Pacific
- Middle
East & Africa
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
to be continued…!
More Valuable Insights Available
FMI, in its new offering, presents an unbiased
analysis of the biopharma plastics market, presenting historical demand data
(2017-2021) and forecast statistics for the period of 2022-2032.
The study divulges essential insights on the Biopharma
Plastics Market by Polymer Type (Polyethylene – PE, Polypropylene – PP,
Acrylonitrile Butadiene Styrene – ABS, Polyethylene Terephthalate – PET,
Polyvinyl Chloride – PVC, Polytetrafluoroethylene – PTFE, Other) by Application
(Protective wear, Container, Bioreactor Bags, Syringes, Depth Filter,
Disposable Medical Connectors, and Others) and Region.
FMI’s Domain Knowledge in Chemicals &
Materials
Our chemical & material consulting team guides
organizations at each step of their business strategy by helping you understand
how the latest influencers account for operational and strategic transformation
in the industrial automation sector. Our expertise in recognizing the
challenges and trends impacting the global chemical & material industry
provides indispensable insights and support – encasing a strategic perspective
that helps you identify critical issues and devise appropriate solutions.
Browse
Full Report @ https://www.futuremarketinsights.com/reports/biopharma-plastics-market
Comments
Post a Comment